financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Hold Opinion On Shares Of T. Rowe Price Group, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Hold Opinion On Shares Of T. Rowe Price Group, Inc.
Mar 13, 2024 11:21 PM

01:50 AM EDT, 03/14/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target price by $10 to $122, valuing TROW at 15.3x our 2025 adjusted EPS estimate of $7.95 (lifted today by $0.30) and at 15.6x our 2024 EPS estimate of $7.80 (upped by $0.40), versus the shares' 3-year average forward multiple of 14.9x and the 12.6x average forward multiple of TROW's closest asset manager peers. We expect revenues in 2024 will be flat to up 5%, and will rise by 1% to 5% in 2025. Revenues in 2023 declined by 0.4%, better than our forecasted decline of 6% to 10%, as a 3.7% decline in investment advisory fees (TROW's main revenue source) was partly offset by a turnaround in performance based revenues. Assets under management (AUM) of $1.44 trillion as of December 31, 2023 rose by 13.3% year-over-year on market appreciation, partly offset by $82 billion of net client outflows. Weighing TROW's premium valuation versus peers with its subpar fund flow trends, we view the shares as fairly valued.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Aptargroup, Inc.
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Aptargroup, Inc.
May 26, 2025
03:30 PM EDT, 05/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target by $4 to $177, valuing ATR at 28.2x our 2025 EPS estimate, a discount to ATR's five-year average forward P/E of 28.8x. Our multiple is...
Research Alert: CFRA Maintains Sell Opinion On Shares Of Posco Holdings
Research Alert: CFRA Maintains Sell Opinion On Shares Of Posco Holdings
May 26, 2025
03:10 PM EDT, 05/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our target price to USD36 from USD34, valuing the stock at 0.30x 2025 P/BV, 40% below its five-year mean. We project revenue to decline by 2% in 2025...
Research Alert: CFRA Keeps Sell Opinion On Shares Of Unitedhealth Group Incorporated
Research Alert: CFRA Keeps Sell Opinion On Shares Of Unitedhealth Group Incorporated
May 26, 2025
02:35 PM EDT, 05/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We slash our 12-month target price to $285 from $379, 10.8x our 2025 EPS estimate, a discount to UNH's historical forward average due to regulatory uncertainty and unfavorable care-related trends...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Vistra Corp.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Vistra Corp.
May 26, 2025
01:10 PM EDT, 05/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target $20 to $180, 28.5x our 2025 EPS estimate (down $0.22 to $6.31; we cut 2026 by $0.32 to $8.08), a premium to fully-regulated peers given...
Copyright 2023-2025 - www.financetom.com All Rights Reserved